Richa Singh,Correspondent,India Pharma Outlook | Monday, 20 November 2023
The pharmaceutical quality control system is projected to experience significant growth, with the market size expected to increase from USD 1.4 billion in 2022 to USD 4.5 billion by 2032. This growth is attributed to higher drug manufacturing costs, a greater demand for high-quality drugs, and a heightened awareness of the importance of quality in healthcare.
The industry is anticipated to expand at a 13.1 percent annual rate over the next decade. Pharmaceutical companies are focusing on quality management systems to guarantee the safety of patients and uphold exceptional standards. Furthermore, in the face of rising costs, quality management systems provide pharmaceutical organizations with a beneficial alternative for improving operational efficiency and lowering expenses.
“Understanding the importance of data integrity and availability of data highlights the need for integrated platforms. Pharma companies have departments taking care of sample analysis, quality management, manufacturing processes, packaging, etc. An integrated quality management platform allows the integration of applications at every level.” Says Sekhar Surabhi, Founder CEO, Caliber Technologies
Compliance with Regulatory Standards
The pharmaceutical industry operates in a highly regulated environment, following strict guidelines set by health authorities globally. It is essential to comply with these regulations, as it is a legal requirement and crucial for ensuring the safety and effectiveness of pharmaceutical products. Data integrity is essential for meeting regulatory standards. Imagine a situation in which a pharmaceutical company is running a clinical trial for a potential new drug.
The regulatory authorities need thorough and precise data in order to assess the safety and effectiveness of the drug. Compromising or manipulating the data collected during the trial could result in severe consequences such as the rejection of the drug application or legal action being taken against the company. In order to prevent these issues, pharmaceutical companies put resources into strong data management systems, enforce strict data integrity policies, and provide regular training for employees. By ensuring compliance with regulatory standards, the organization also promotes a culture of transparency and accountability.
"There is an increasing demand for consultancy services to develop the right infrastructure for regulatory compliance and standards. A comprehensive overview on varying industry standards as product and packaging accepts a wide variance is essential for authentication and reliability of extended compliance consultation.” Dr. Gautam Sharma founder of Neozenith Corporation.
Maintaining Product Quality and Patient Safety
In the pharmaceutical industry, ensuring the quality of the final product is absolutely essential and cannot be compromised. The well-being of patients depends on the precision and reliability of the medications they take. The quality of pharmaceutical products is directly affected by data integrity, which includes ensuring that the data is accurate, reliable, and complete throughout the manufacturing process. Imagine a pharmaceutical manufacturing facility where even a small change in the drug formulation could put patient safety at risk. Compromised data on ingredients, proportions, and manufacturing processes may lead to the creation of low-quality or unsafe drugs.
This may result in negative impacts on patients, product recalls, and harm to the company's reputation, and legal consequences. In order to reduce these risks, pharmaceutical companies put in place data integrity measures throughout the entire manufacturing process. This involves the utilization of electronic systems to securely record and store data in an unchangeable manner. Furthermore, regular audits and inspections are carried out to guarantee that the data produced meets the quality standards established by regulatory authorities.
The access to quality and affordable healthcare remains inequitable across large parts of the country, the medical devices sector, including the hospital furniture segment, has grown considerably and plays a critical role in improving the access and affordability of healthcare services”, Says Suresh Rathi Managing Director at Plastic Molding Manufacturing.
Facilitating Continuous Improvement and Innovation
Ensuring data integrity is not only a box to check for compliance; it drives ongoing progress and creativity within the pharmaceutical field. Precise and dependable data is essential for making well-informed decisions, allowing companies to pinpoint areas for enhancement, streamline processes, and foster innovation in drug development and manufacturing. Picture a group of pharmaceutical researchers and developers collaborating on a new formulation to improve the drug's bioavailability. Accurate information regarding the drug's physicochemical properties, absorption kinetics, and patient outcomes is crucial for making well-informed decisions throughout the development process.
In the event of a data breach, there is a risk that the team could make erroneous assumptions, resulting in the creation of a product that is ineffective or unsafe. In order to promote a mindset of constant improvement and creativity, pharmaceutical companies are investing in technologies that guarantee data integrity, such as electronic lab notebooks and integrated data management systems. By enhancing the efficiency of research and development processes, this also positions the company for success in a highly competitive market.
"The areas of automation, robotics, machine learning, artificial intelligence, data-driven experimentation, modelling, predictive science, and the integration of all these facets will transform API development over the next decade. The industry must develop the ability to predict experimental outcomes more accurately and be able to produce a greater number of experiments per unit time, with reduced human intervention, ultimately helping deliver life-saving drugs to patients at accelerated speed.” Says Bhuvaneswari Sridhar, AVP, Small Molecule Technology, Pfizer India.
Data integrity is a crucial aspect of quality control in the pharmaceutical industry, where human lives are on the line, rather than just a trendy term. The examples we talked about highlight the extensive consequences of compromised data integrity, which include failing to meet regulations and putting patient safety at risk. Pharmaceutical companies prioritize data integrity to meet regulatory standards and advance healthcare by delivering safe, effective, and innovative products. During a time of fast technological progress, it is essential for the pharmaceutical industry to adopt strong data integrity practices in order to achieve long-term success. It is not just a necessity, but a strategic imperative.